NZCity NewsLinks -

Finance

29 Apr 2024

Search

EBOS announces appointment of new Chief Financial Officer
EBOS Group Limited (“EBOS”) is pleased to announce the appointment of Alistair Gray to the role of Chief Financial Officer (“CFO”) with effect from 30 September 2024

Julie Tay appointed as independent director
EBOS Group Limited (EBOS) is pleased to announce the appointment of Julie Tay as an independent director, effective 15 May 2023

EBOS - Advance Notice - Full Year Results
EBOS Group Limited will announce its full year financial results for the year ended 30 June 2022 on Wednesday, 24 August 2022

ACCC Announcement Regarding LifeHealthcare Acquisition
EBOS Group Limited (EBOS) notes the announcement by the Australian Competition and Consumer Commission (ACCC) today that it will not oppose the proposed acquisition of LifeHealthcare announced on 9 December 2021

EBOS raises first half profit by 15.8% to record $1118m
Dual-listed EBOS Group said strong revenue growth in its key healthcare and animal care businesses drove its underlying net profit up by 15.8 per cent to a record A$109.3 million ($118m) in the six months to December.The diversified...

Ebos Group Limited (NZX: EBO) Retail Offer Oversubscribed
EBOS is pleased to announce that its non-underwritten NZ$105 million (A$100 million) retail offer (Retail Offer) in connection with the agreement to acquire LifeHealthcare has closed oversubscribed

Ebos buys healthcare company for $1.3b; eyes growth in Asia
Ebos says the acquisition of LifeHealthcare will help it expand into South East Asia.

EBOS to buy LifeHealthcare for A$1.17b in debt and share deal
EBOS Group said it had entered into a deal to buy medical device distributor LifeHealthcare from funds advised by private equity firm Pacific Equity Partners and other minority holders.The purchase comprises 100 per cent of LifeHealthcare's...

EBOS lifts net profit by 14 per cent to record $185m, raises dividend
EBOS said its business had proven to be resilient throughout the Covid-19 pandemic, with continued strong performances from its healthcare and animal care businesses driving its net profit up by 14 per cent to a record $185.3 million...

EBOS increases its shareholding in Transmedic to 90%
EBOS Group Limited (EBOS) is pleased to announce that it has (via one of its wholly owned subsidiaries) increased its shareholding in Transmedic Pte Ltd (Transmedic) from 51% to 90%

EBOS earnings rocket up 21pc to new record, lifts dividend
Medical supplies and animal healthcare company EBOS Group said strong first half growth was replicated in the second, driving underlying net profit up 21.3 per cent to a record A$228.2 million in the June year, its 100th year of operation.The...

EBOS advises that TerryWhite Chemmart network reaches 500 stores
EBOS Group Limited (“EBOS”) is pleased to advise that TerryWhite Chemmart (“TWC”) has celebrated the opening of its 500th network pharmacy. This milestone demonstrates the strength and momentum of the TWC franchise

Ebos Group Limited (NZX: EBO) Half Year Results
EBOS today announced another record result for the first half of the 2022 financial year, including double-digit underlying earnings growth.The Directors declared an interim dividend of NZ 47.0 cents per share, an increase of 10.6% on the prior period

Ebos Group Limited (NZX: EBO) EBOS Announces Successful Placement
EBOS is pleased to announce the successful completion of the fully underwritten placement of approximately 19.5 million new fully paid ordinary shares, raising approximately NZ$674 million / A$642 million to partly fund the acquisition of LifeHealthcare

Ebos Group Limited (NZX: EBO) Full Year Results
EBOS Group Limited today announced another record result for the 2021 financial year. The Directors declared a final dividend of NZ 46.0 cents per share, an increase of 15.0% on the prior year